Compare International Business Machines Corp (IBM) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
International Business Machines Corp vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? International Business Machines Corp trades at $228.45 (market cap $217.43B), while Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B). The key difference: International Business Machines Corp is far larger — about 30.6× Ionis Pharmaceuticals Inc. Common Stock's market cap, and International Business Machines Corp pays a 2.93% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Business Machines Corp for 89 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| IBM | IONS | |
|---|---|---|
Market Cap | $217.43B | $7.10B |
Volume | 5,119,486 | 2,027,457 |
Sector | Technology | Health |
52-Week High | $329.23 | $86.50 |
52-Week Low | $205.77 | $42.38 |
Typical Hold Time | 89 Days | 0 Days |
Enterprise Value | $274.57B | $6.66B |
Dividend Yield | 2.93% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IBM stock trades at $230.78, up 1.66% with recent momentum driven by positive consulting sector sentiment and the launch of self-hosted deployment for its Bob AI platform. The company shows strong fundamentals with 2025 revenue of $67.54B and net income of $10.59B, though technical indicators signal bearish pressure. Recent earnings performance has been mixed with Q2 2026 missing expectations, while analyst consensus remains positive with a $255.50 price target.
IBM presents a balanced investment case with solid profitability metrics (15.52% net margin, 34.62% ROE) and growing AI consulting business ($5.5B book), but faces risks from cyclical mainframe weakness and competitive pressures. The stock trades at reasonable valuations (P/E 20.5) with upside potential if AI initiatives drive sustained growth.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About International Business Machines Corp
International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →
